TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib

Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS National Pharmaceuticals — Fulvestrant, Darunavir and Imatinib". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)Scope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
46Bids / Report
1.7% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England)
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSFramework
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published4 Mar 2021, 10:27 GMT
Last source update4 Mar 2021, 10:27 GMT
Recurring procurementNot published
ClassificationPharmaceutical products
Delivery area
UK
OCIDocds-h6vhtk-029839
What is being bought
Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021.
What changed
From the official release history
  1. Status changed to complete
    4 Mar 2021, 10:27 GMT
  2. Official notice release published
    4 Mar 2021, 10:27 GMT
  3. Buyer information updated
    4 Mar 2021, 10:27 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    Project title: invitation to offer for NHS National Pharmaceuticals – Fulvestrant, Darunavir and Imatinib Offer reference number: CM/PHG/20/5627Period of framework agreement: start date to be confirmed with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months potential periods of call-offs under the framework agreement: Fulvestrant: All regions: to commence as soon as possible with an end date of 1 May 2021 Darunavir: CESW Region: to commence as soon as possible with an end date of 1 May 2021 Imatinib: All regions: to commence as soon as possible with an end date of 31 October 2021. Additional information: Price is not the only award criterion and all criteria are stated in the procurement documents.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    4 Mar 2021, 10:27 GMT
  2. Award active
    Not published · Not published
  3. Award active
    Not published · Not published
  4. Award active
    Not published · Not published
  5. Award active
    Not published · Not published
  6. Award active
    Not published · Not published
  7. Award active
    Not published · Not published
  8. Award active
    Not published · Not published
  9. Award active
    Not published · Not published
  10. Award active
    Not published · Not published
  11. Award active
    Not published · Not published
  12. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  13. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  14. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  15. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  16. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  17. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  18. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  19. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  20. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
  21. Contract active
    Signed 15 Jan 2021, 00:00 GMT · £1
Commercial outcome and competition
Awards
Accord-UK Ltd
Not published · Not published · active
Novartis Pharmaceuticals UK Ltd
Not published · Not published · active
Thornton and Ross Ltd
Not published · Not published · active
Zentiva Pharma UK Ltd
Not published · Not published · active
AstraZeneca
Not published · Not published · active
Cipla (EU) Ltd
Not published · Not published · active
Dr.Reddy's Laboratories (UK) Limited
Not published · Not published · active
Janssen-Cilag Ltd
Not published · Not published · active
Sandoz Ltd
Not published · Not published · active
Teva UK Limited
Not published · Not published · active
Contracts
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Contract
£1 · signed 15 Jan 2021, 00:00 GMT · active
Bid statistics
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
bids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
electronicBids: 16 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
smeBids: 8 (lot 1)
Buyer and organisations in this procedure

The NHS Commissioning Board (operating under the name of NHS England)

Contracting authority GB-FTS-2505
View buyer profile

  • The NHS Commissioning Board (operating under the name of NHS England)
    buyer

    2nd Floor, Rutland House, Runcorn, UK, WA7 2ES
    gemma.tomlinson1@nhs.net

  • Accord-UK Ltd
    supplier

    Barnstaple, UK

  • AstraZeneca
    supplier

    Luton, UK

  • Cipla (EU) Ltd
    supplier

    Addlestone, UK

  • Dr.Reddy's Laboratories (UK) Limited
    supplier

    Beverley, UK

  • Janssen-Cilag Ltd
    supplier

    High Wycombe, UK

  • Novartis Pharmaceuticals UK Ltd
    supplier

    London, UK

  • Sandoz Ltd
    supplier

    Camberley, UK

  • Teva UK Limited
    supplier

    Castleford, UK

  • The High Court
    reviewBody

    Strand, London, WC2A 2LL
    generaloffice@administrativecourtoffice.justice.gov.uk

  • Thornton and Ross Ltd
    supplier

    Huddersfield, UK

  • Zentiva Pharma UK Ltd
    supplier

    London, UK
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published